Wide-ranging Infectious Disease Expertise

Therapeutic Depth: Infectious Disease

Wide-ranging Infectious Disease Expertise

Therapeutic Depth: Infectious Disease

Infectious diseases kill a child almost every three seconds. Every day 3,000 people die from malaria. 1.5 million people die each year from tuberculosis. In an era of vaccines and antibodies, infectious diseases that should be under control rage on in many developing countries.

SynteractHCR has a breadth of experience managing infectious disease studies. With immunization estimated to avert between two to three million deaths each year, SynteractHCR is committed to quality clinical development of vaccinations and supporting the study of infectious diseases in adult and pediatric populations the world over.

SynteractHCR has successfully performed a diverse range of Phase I- IV studies, including:

  • Comparing and Characterizing (different parameters)
  • Dose Escalation
  • Dose-finding and Safety
  • Feasibility
  • Immunogenicity
  • Long-term Follow-up (antibodies)
  • Protective Efficacy
  • Safety Immunogenicity in Children and Adolescents
  • Tolerability

SynteractHCR has expertise in:

  • Concomitant Administrations of Meningococcal and Pneumococcal
  • Conjugated Meningitis
  • Hepatitis A
  • Human Immunodeficiency Virus
  • Influenza
  • Rabies
  • Recombinant Hypoallergenic Grass Pollen
  • Smallpox Booster
  • Subcutaneous Immunotherapy
  • Tick-borne Encephalitis

Experienced In Managing Diverse Infectious Disease Studies

We have successfully managed more than 160 infectious disease related studies in 32,000+ patients at 759 sites worldwide.

Get in Touch

Global Headquarters:
5759 Fleet Street, Suite 100
Carlsbad, CA 92008

Phone: +1 760 268 8200
Fax: +1 760 929 1419

x

Contact SynteractHCR

Tell us how to stay in touch with you:


Required(*)
Cancel